Nadjib Hammoudi1, Gilles Montalescot1. Show Affiliations » 1. Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.
Abstract
Mesh: See more » Atrial FibrillationFibrinolytic AgentsHumansPercutaneous Coronary InterventionRandomized Controlled Trials as Topic
Substances: See more » Fibrinolytic Agents
Year: 2018 PMID: 29762701 DOI: 10.1093/eurheartj/ehy216
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983